A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

Clinical trial NCT07094516 · RECRUITING

Trial details

NCT number: NCT07094516
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2025-08-07
Primary completion: 2028-09-14
Enrollment: 407

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.